IXCHIQ® was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV) Antibody levels ...

MBX Biosciences, Inc. is rated a Buy, driven by canvuparatide's once-weekly dosing advantage in hypoparathyroidism. Learn ...

Netflix has admitted it did not attribute any value to Warner Bros.’ video game business in its $82.7 billion acquisition deal, sparking concern for the future of everything from Mortal Kombat to ...

The company, which sells software that helps users practice important conversations, last week announced a $40 million round, ...

Potent CAR-T expansion from a single, off-the-shelf infusion without chemotherapy ...

March Bio is continuing enrollment in the Phase 2 trial, with the Independent Data Monitoring Committee's approval to advance to Simon Stage 2 of the Phase 2 trial. The Company anticipates presenting ...

InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that three studies of its novel BCL2 ...

The ASH oral presentation today reports data from the ongoing dose escalation and dose expansion parts of the CARDINAL study of TERN-701 in patients with previously treated CML. As of the September 13 ...

The 2025 meeting of the American Society of Hematology features some of the newest developments in blood cancers and rare ...

The five-year-old start-up, which has just 52 employees and is profitable, is now valued at $2.1 billion by investors including Andreessen Horowitz. By Niko Gallogly As an investment banker and ...

SEATTLE — Western Washington business owners are frustrated they've been erased from parts of Google’s search engine, according to several businesses that reached out to KING 5. "We just have to keep ...

Presentations are big business. When movie stars such as Leonard DiCaprio and Matthew McConaughey get up to a million dollars for a single speech, and former presidents, such as Barack Obama, $400,000 ...